Considerable Economic Burden for Vaccine-Preventable Diseases

This article originally appeared here.
Share this content:
Considerable Economic Burden for Vaccine-Preventable Diseases
Considerable Economic Burden for Vaccine-Preventable Diseases

TUESDAY, Oct. 18, 2016 (HealthDay News) -- For U.S. adults, the economic burden associated with vaccine-preventable diseases was estimated at about $9 billion in 2015, according to a study published in the October issue of Health Affairs.

Noting that low rates of vaccine uptake lead to costs to individuals and society, Sachiko Ozawa, Ph.D., from the University of North Carolina at Chapel Hill, and colleagues calculated the current economic burden attributable to vaccine-preventable diseases among U.S. adults.

The researchers estimated that in 2015, the total remaining economic burden was approximately $9 billion from vaccine-preventable diseases related to 10 vaccines recommended for adults aged 19 years and older. Almost 80 percent of the financial burden ($7.1 billion) was due to unvaccinated individuals.

"These results not only indicate the potential economic benefit of increasing adult immunization uptake but also highlight the value of vaccines," the authors write. "Policies should focus on minimizing the negative externalities or spillover effects from the choice not to be vaccinated, while preserving patient autonomy."

Two authors are employees of Merck and Company, which partially funded the study.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

Low-Dose Hyaluronidase Can Remove Hyaluronic Acid Fillers

Low-Dose Hyaluronidase Can Remove Hyaluronic Acid Fillers

Greater resolution of nodules with hyaluronidase versus saline; more rapid resolution with higher doses

Improvement in Race-Based Disparities in Years of Life Lost

Improvement in Race-Based Disparities in Years of Life ...

Decline in race-based disparities in years of life lost seen in the United States from 1990 to 2014

Drug-Related Endocarditis Cases Up From 2007 to 2015

Drug-Related Endocarditis Cases Up From 2007 to 2015

Increase in endocarditis over nine-year study period mirrored increase in concomitant mixed drug use

is free, fast, and customized just for you!

Already a member?

Sign In Now »